Nasdaq · Healthcare
DocGo Inc. (DCGO)
As-reported financials and recent SEC filings for DocGo Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$322.2M
Net income
$-182.4M
Net margin
-56.6%
Diluted EPS
$-1.84
ROE
-144.9%
P/E (TTM)
—
Market cap
$48.4M
Debt / equity
0.0×
Income statement (as reported)
| Line | FY2025 | FY2025 | FY2025 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $322.2M | $616.6M | $624.3M | $440.5M | $318.7M |
| Gross profit | — | — | — | $-83.4M | $-133.0M |
| Operating income | $-178.0M | $28.7M | $15.1M | $21.8M | $15.4M |
| Net income | $-182.4M | $20.0M | $6.9M | $34.6M | $23.7M |
| Diluted EPS | $-1.84 | $0.18 | $0.06 | $0.34 | $0.25 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-18
View on EDGAR →42026-05-14
View on EDGAR →8-K2026-05-11
View on EDGAR →10-Q2026-05-11
View on EDGAR →8-K2026-04-22
View on EDGAR →ARS2026-04-22
View on EDGAR →DEFA14A2026-04-22
View on EDGAR →DEF 14A2026-04-22
View on EDGAR →Go deeper on DCGO
Search DocGo Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.